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Background: Depression is a major public health problem among adults with arthritis and other rheumatic disease.
The purpose of this study was to conduct a systematic review of previous meta-analyses addressing the effects of
exercise (aerobic, strength or both) on depressive symptoms in adults with osteoarthritis, rheumatoid arthritis,
fibromyalgia and systemic lupus erythematous.
Methods: Previous meta-analyses of randomized controlled trials were included by searching nine electronic databases
and cross-referencing. Methodological quality was assessed using the Assessment of Multiple Systematic Reviews
(AMSTAR) Instrument. Random-effects models that included the standardized mean difference (SMD) and 95%
confidence intervals (CIs) were reported. The alpha value for statistical significance was set at p ≤ 0.05. The U3 index,
number needed to treat (NNT) and number of US people who could benefit were also calculated.
Results: Of the 95 citations initially identified, two aggregate data meta-analyses representing 6 and 19 effect sizes in
as many as 870 fibromyalgia participants were included. Methodological quality was 91% and 82%, respectively.
Exercise minus control group reductions in depressive symptoms were found for both meta-analyses (SMD, −0.61,
95% CI, −0.99 to −0.23, p = 0.002; SMD, −0.32, 95% CI, −0.53 to −0.12, p = 0.002). Percentile improvements (U3) were
equivalent to 22.9 and 12.6. The number needed to treat was 6 and 9 with an estimated 0.83 and 0.56 million US
people with fibromyalgia potentially benefitting.
Conclusions: Exercise improves depressive symptoms in adults with fibromyalgia. However, a need exists for
additional meta-analytic work on this topic.Background
Arthritis is a broad term used to describe more than 100
rheumatic diseases and conditions that affect joints as
well as the surrounding tissues around joints [1]. The
most common form of disability in the United States
(US), arthritis affects all racial and ethnic groups and is
more common in women than men [1]. Based on 2007–
2009 data, the prevalence of doctor-diagnosed arthritis in
the US was reported to be 50 million, or about 20%, of all
adults [2]. In terms of costs, an increase of 41.8 billion
dollars in total costs (from 86.2 to 128 billion dollars) was
reported between 1997 and 2003 in the US [3].
Four common types of arthritis and other rheumatic
diseases are osteoarthritis, rheumatoid arthritis, fibro-* Correspondence: gkelley@hsc.wvu.edu
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article, unless otherwise stated.myalgia and systemic lupus erythematous. More spe-
cifically, the prevalence of osteoarthritis, rheumatoid
arthritis, fibromyalgia and systemic lupus erythematous
have been estimated to be 27 million [4], 1.5 million [5], 5
million [4], and 161,000 [4], respectively. A common prob-
lem among adults with arthritis is depression. For example,
a recent study that included 1,793 US adults 45 years of
age and older with arthritis found that 18% had depression
while only slightly more than half (51.3%) sought help for
their depression [6].
One potential treatment option for adults with arth-
ritis and depression is exercise, a low-cost nonpharma-
cologic intervention that is available to the vast majority
of the general population. Systematic reviews with meta-
analysis, a quantitative approach for combining the results
of different studies on the same topic [7], are considered
by many to be the most important type of evidence fortral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ments on selected outcomes [8,9]. Unfortunately, with the
proliferation of systematic reviews on the same topic, it be-
comes difficult to make informed decisions regarding the
effects of various interventions on selected outcomes. For
example, a recent systematic review identified 33 previous
meta-analyses examining the effects of exercise on blood
pressure [10]. Given the proliferation of systematic reviews,
with or without meta-analysis on the same topic, a need
now exists to systematically review these previous reviews
in order to provide decision-makers and practitioners with
the information they need to make evidence-based deci-
sions regarding the efficacy and effectiveness of various
interventions on selected outcomes as well as provide re-
searchers with direction for future research [11]. Given
the former, the purpose of the current study was to con-
duct a systematic review of previous meta-analyses ad-
dressing the effects of exercise (aerobic, strength training
or both) on depressive symptoms in adults with osteo-




The a priori inclusion criteria for this study were as fol-
lows: (1) previous systematic reviews with meta-analysis
of randomized controlled trials or data reported separ-
ately for randomized controlled trials if the meta-
analysis included other study designs, (2) adults 18 years
of age and older with osteoarthritis, rheumatoid arthritis,
fibromyalgia or systemic lupus erythematous, as de-
fined by the inclusion criteria of the authors of the
original meta-analyses, (3) aerobic and/or strength training
intervention(s) lasting an average of at least 4 weeks,
(4) published and unpublished (dissertations and master’s
theses) studies in any language, (5) exercise minus control
group difference in depressive symptoms as a primary out-
come in the original meta-analysis and reported as the
standardized mean difference (SMD). Meta-analyses were
limited to randomized controlled trials because they are
the only way to control for unknown confounders as
well as the fact that nonrandomized controlled trials
tend to overestimate the effects of treatment in health-
care interventions [12,13]. In addition, meta-analyses in
which the focus was on acute studies, for example stud-
ies in which participants would perform one or more
bouts of exercise and then immediately be assessed for
depressive symptoms, were avoided. Given the different
instruments used to assess depressive symptoms, the inclu-
sion of meta-analyses were limited to those in which the
SMD was reported. Any studies that did not meet all of
the above criteria were excluded. Ineligible studies were ex-
cluded based on at least one of the following: (1) inappro-
priate population (for example, children), (2) inappropriateintervention (for example, pharmacologic), (3) inappro-
priate comparison (for example, exercise versus pharma-
cologic), (4) inappropriate outcome (for example, anxiety),
(5) inappropriate study type (for example, meta-analysis
that included non-randomized controlled trials, systematic
review without meta-analysis).
Data sources
Using the graphical-user interfaces for each database, the
following electronic sources were searched from their
inception forward: (1) PubMed (1966 to July 4, 2013),
(2) Sport Discus (1975 to July 4, 2013), (3) Web of Science
(1955 to July 4, 2013), (4) Scopus (1823 to July 4, 2013),
(5) Proquest (1861 to July 4, 2013), (6) Cochrane Database
of Systematic Reviews (1996 to July 4, 2013), (7) Physio-
therapy Evidence Database [(PEDRO) (1929 to July 5,
2013)], (8) Database of Abstract of Reviews of Effects
(DARE) (1991 to July 5, 2013), (9) Health Evidence Canada
(HEC) (1985 to July 5, 2013). Scopus was included in our
database searches because it has been reported to provide
coverage of Embase, a database that was not available to
us [14]. While the specific search strategies varied depend-
ing on the database searched, key terms or forms of key
terms included exercise, physical activity, physical fitness,
arthritis, fibromyalgia, lupus, randomized, depression,
systematic review and meta-analysis. A copy of the
search strategies used for each database can be found in
Additional file 1. After removing duplicates, the overall
precision of the searches was calculated by dividing the
number of studies included by the total number of studies
screened [15]. The number needed to read (NNR) was
then calculated as the inverse of the precision [15]. In
addition to electronic database searches, cross-referencing
for potentially eligible meta-analyses from retrieved reviews
was also conducted. All studies were stored in Reference
Manager, version 12.0 [16].
Study selection
All studies were selected by both authors, independent
of each other. They then met and reviewed their selec-
tions for agreement. Any disagreements were resolved
by consensus.
Data abstraction
Prior to data abstraction, coding sheets were developed
in Microsoft Excel 2010 [17]. The coding sheets could
hold up to 193 items from each included meta-analysis.
Both authors coded all studies independent of each other.
Upon completion of coding, all coding sheets were merged
into one common codebook and reviewed by both authors
for correctness. Disagreements were resolved by consensus.
Using Cohen’s kappa statistic [18], the overall agreement
rate prior to correcting discrepancies was k = 0.88, consid-
ered to be “almost perfect” [19].
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Methodological quality for each included meta-analysis
was assessed using the Assessment of Multiple System-
atic Reviews (AMSTAR) Instrument [20-23]. AMSTAR
was chosen over other instruments [24,25] because of its
reported inter-rater reliability (k = 0.70), construct valid-
ity (intra-class correlation coefficient = 0.84) and feasibil-
ity (average of 15 minutes per study to complete) [22].
The 11-item questionnaire is designed to elicit responses
of “Yes”, “No”, “Can’t Answer”, or “Not Applicable”. The
response “Can’t Answer” is chosen when an item is rele-
vant but not described. The response “Not Applicable” is
chosen when an item is not relevant (for example, meta-
analysis of data not possible) [20-23]. For consistency
when summing responses, the following question was
modified from “Was the status of publication (i.e. grey
literature) used as an inclusion criterion?” to “Was the
status of publication (i.e. grey literature) as an inclusion
criterion avoided?” In addition, we considered the question
regarding conflict of interest as adequately met if the au-
thors of the systematic review provided a statement on
conflict of interest versus the reporting of conflict of inter-
est by both the authors of the systematic review and all the
original studies included in the meta-analysis. Both au-
thors, independent of each other, assessed methodological
quality. They then met and reviewed every item for agree-
ment. Disagreements were resolved by consensus. The
overall agreement rate prior to correcting discrepancies
was k = 0.94, considered to be “almost perfect” [19].
Data synthesis
The main results from each meta-analysis were extracted
a priori [7] with a focus on random-effects models be-
cause they incorporate between-study heterogeneity into
the model [26,27]. The SMD, 95% confidence intervals
(CIs) and associated z and alpha value for z were ab-
stracted or calculated if sufficient data were available to
do so. Standardized mean differences were classified as
trivial (<0.20), small (0.20 to 0.49), medium (0.50 to
0.79) or large (>0.80) [28]. Two-tailed alpha values ≤ 0.05
along with non-overlapping 95% CIs were considered as
statistically significant. The Q statistic, a measure of het-
erogeneity, was also extracted for each outcome. An
alpha value ≤ 0.10 was considered to represent statisti-
cally significant heterogeneity [29]. Because of issues sur-
rounding the power of the Q statistic, the I2 statistic was
also reported if it was provided in the meta-analysis or
calculated if sufficient data existed to do so [29]. Values
were considered to be representative of low (0 to 25%),
moderate (25 to 50%), large (50 to 75%) or very large
(>75%) inconsistency [29]. In addition to Q and I2, tau-
squared (τ2) was also reported or calculated if sufficient
data were available. An a priori decision was made to
not pool results from the different meta-analysis becauseof the expectation that many of the same studies would
be included in the different meta-analyses, thus violating
the assumption of independence. Post hoc, a decision
was made to pool the results of one included meta-
analysis [30] that reported separate results for studies that
met the American College of Sports Medicine (ACSM)
Guidelines for aerobic fitness [31,32] (4 studies), those that
did not meet the recommendation (1 study), and those in
which strength training was performed (1 study). The ra-
tionale for this decision was based on the desire to exam-
ine exercise in a broader context. However, results were
also reported separately as was done in the original meta-
analysis [30].
Since it was assumed that none of the eligible meta-
analyses would include 95% prediction intervals (PIs),
these were calculated if the findings were statistically
significant and the results from each study included
in each meta-analysis were provided [33-35]. Prediction
intervals are used to estimate the treatment effect in a
new trial [33-35] and may be more appropriate in deci-
sion analysis [36].
In order to enhance practical application, the number-
needed-to treat (NNT) was calculated for any overall
findings that were reported as statistically significant.
This was accomplished using the approach suggested by
the Cochrane Collaboration and was based on a control
group risk of 30% [8]. Since both included meta-analyses
were limited to depressive symptoms in those with fibro-
myalgia [30,37], a post hoc decision was made to provide
a gross estimate, based on the NNT results, of the num-
ber of US people with fibromyalgia who could improve
their depressive symptoms by starting and maintaining a
regular exercise program. Estimates were based on previ-
ous research showing that approximately 5 million people
in the US have fibromyalgia [4]. In addition, Cohen’s U3
index was used to determine the percentile gain in the
intervention group [38]. For example, a SMD of 0.50 sug-
gests that on average, a person in the exercise group would
be at the 69th percentile in terms of improving their de-
pressive symptoms. This translates into being 19 percen-
tiles higher than the control group [39].
If not already provided and if sufficient data were
available to do so, small-study effects (for example,
publication bias) were assessed quantitatively using the
regression-intercept approach of Egger et al. [40]. One-
tailed alpha values ≤ 0.05 for t were considered to be rep-
resentative of statistically significant small-study effects.
In addition, influence analysis was conducted with each
SMD deleted from the model once. Cumulative meta-
analysis, ranked by year, was also conducted to examine
results over time [41]. In addition, since one meta-
analysis [37] included studies in which there were active
control groups (hot packs, stretching, etc.), we used a
two-category, mixed-effects ANOVA model to compare
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control groups versus all other included controls (usual
care and attention control). A between group alpha level
≤ 0.05 was considered to be statistically significant.
Negative SMDs were indicative of benefit, i.e., de-
creases in depressive symptoms. Analyses were carried
out using Comprehensive Meta-Analysis (version 2.2) [42]
and Microsoft Excel 2010 [17].
Results
Characteristics of included meta-analyses
Of the 95 citations initially identified, 69 (72.6%) remained
after removing duplicates. Of the 69 articles that were
screened, two aggregate data meta-analyses, both in partic-
ipants with fibromyalgia, met the criteria for inclusion
[30,37]. Post hoc, one study that was initially included was
removed because it was not focused specifically on the ef-
fects of exercise on depressive symptoms in adults with a
specific type of arthritis or other rheumatic disease, but ra-
ther, in adults with a variety of chronic illnesses [43]. The
precision of the searches was 0.03 while the NNR was 35.
The major reasons for exclusion of ineligible studies were
an inappropriate study design (48.4%) followed by an in-
appropriate intervention (17.9%), population (18.9%), out-
come (9.5%) and comparison (6.3%). No meta-analysis was
deleted because they did not report their results as a SMD.
A flow diagram that depicts the search process can be
found in Figure 1 while a list of all excluded studies, in-
cluding the reasons for exclusion, is shown in Additional
file 2. For the two included meta-analyses [30,37], one in-
cluded studies on aerobic or strength training exercise [30]
while the second was limited to aerobic exercise studies
but also included studies in which participants performed
strength training as long as the number of minutes of
strength training did not exceed the number of minutes
spent performing aerobic exercise [37]. Both meta-analyses
included fibromyalgia participants as defined by the diag-
nostic criteria of the original studies [30,37]. A general de-
scription of the characteristics of each meta-analysis is
provided in Table 1.
Methodological quality
Item by item results for each meta-analysis using the
AMSTAR instrument is shown in Additional file 3. The
meta-analysis by Busch et al. [30] satisfied 10 of the 11
(91%) of the AMSTAR criteria while the study by Hauser
et al. [37] met 9 of the 11 criteria (82%). One meta-
analysis was judged as (1) not avoiding the status of pub-
lication as an inclusion criterion and (2) not providing a
list of excluded studies [37].
Data Synthesis
The overall results for both included systematic reviews
with meta-analysis are shown in Table 2. As can be seen,SMD reductions in depressive symptoms included non-
overlapping confidence intervals for both with one
meta-analysis yielding a small SMD [37] and one yield-
ing a medium SMD [30]. While the overall SMD was
approximately twice as large for the Busch et al. meta-
analysis [30], the between-meta-analysis 95% CIs for
both were overlapping, suggesting no statistically signi-
ficant difference between the two studies [30,37]. In
addition, the pooled SMD for the Busch et al. meta-
analysis was the result of the current investigative team
combining the results from those studies meeting the
ACSM guidelines for aerobic exercise with the one
strength training study and one aerobic study not meet-
ing the ACSM recommendations, as reported by the au-
thors [30]. A statistically significant and a large amount
of heterogeneity were found for both meta-analyses as
well as overlapping 95% PIs [30,37]. Data for the NNT,
number who could benefit and percentile improvement
are shown in Table 3. No small-study effects were ob-
served for the overall meta-analysis results of Busch et al.
[30] (β0, -3.8, 95% CI, −10.9 to 3.3, p = 0.11) while statisti-
cally significant small study effects were observed for the
Hauser et al. [37] meta-analysis (β0, -2.4, 95% CI, −4.8
to −0.01, p = 0.02). With each study deleted from the over-
all model once for each meta-analysis [30,37], SMD
changes in depressive symptoms remained statistically sig-
nificant with non-overlapping confidence intervals. Results
ranged from −0.49 (95% CI, −0.12 to −0.85, p = 0.009)
to −0.72 (95% CI, −0.35 to −1.10, p < 0.0001) in the
study by Busch et al. [30], and −0.23 (95% CI, −0.08
to −0.38, p = 0.003) to −0.36 (95% CI, −0.15 to −0.57,
p = 0.001) in the study by Hauser et al. [37]. Cumulative
meta-analysis, ranked by year, revealed that SMD changes
in depressive symptoms have remained statistically signifi-
cant with non-overlapping confidence intervals since 2001
for the meta-analysis by Busch et al. [30] (range of years,
1996 to 2004) and from 2004 onward in the meta-analysis
by Hauser et al. [37] (range of years, 1996 to 2009). No
statistically significant difference was found between active
control groups and the other types of control groups
included in the Hauser et al. meta-analysis (Qb = 1.13,
p = 0.29) [37].
Subgroup results were provided for both meta-analyses
[30,37]. For the Busch et al. meta-analysis [30], results
for depressive symptoms were reported according to
studies meeting the ACSM recommendations for aerobic
exercise, [30,31] (4 studies), those not meeting the rec-
ommendations (1 study) and those limited to strength
training exercise (1 study). For those studies meeting the
ACSM recommendations, a statistically significant reduc-
tion in depressive symptoms was observed (SMD, −0.40,
95% CI, −0.04 to −0.76, p = 0.003). The SMD for the
study not meeting the recommendations was −1.22 (95%
CI, −1.90 to −0.54) while the SMD for the study in which
Initial records identified 
(n=95)
- PubMed (n=19) - Cochrane (n=1)
- SportDiscus (n=0) - PEDro (n=4)
- Web of Science (n=22) - DARE (n=32)
- Scopus (n=5) - HEC (n=1)
- Proquest (n=8) - Cross-referencing (n=3)
Records after duplicates removed 
(n=69)
Initial records screened based on title and 
abstract 
(n=69)
Records excluded (n=59), with 
reasons*
- Inappropriate population (n=16)
- Inappropriate intervention (n=17)
- Inappropriate comparison (n=6)
- Inappropriate outcome (n=9)
- Inappropriate study design (n=39)
Full-text articles 
assessed for eligibility 
(n=10)
Records excluded (n=8), with 
reasons*
- Inappropriate population (n=2)
- Inappropriate intervention (n=0)
- Inappropriate comparison (n=0)
- Inappropriate outcome (n=0)


























Figure 1 Flow diagram for the selection of studies. *, number of reasons exceeds the number of studies because some studies were
excluded for more than one reason.
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to −0.20). Subgroup analyses in the study by Hauser et al.
[37] included results partitioned according to two studies
in which low intensity exercise (50% to 60% of maximum
heart rate) was compared to moderate intensity exercise
(60% to 80% of maximum heart rate) as well as eight
studies in which land-based exercise was compared
to water-based exercise. The authors reported no statisti-
cally significant differences between either low or moder-
ate intensity exercise (SMD, −0.16, 95% CI, −0.67 to 0.13,
p = 0.53) or land versus water-based exercise (SMD, −0.44,
95% CI, −0.88 to 0.01, p = 0.05).Table 1 General characteristics of included meta-analyses
Reference Year Studies Participants
Busch et al. [30] 2007 6 294 primarily women (154 exercise, 137 c
all with fibromyalgia, 33–50 years of a
X  SD; 41:1 5:2ð Þ
Hauser et al. [37] 2010 18 870 primarily women (456 exercise, 414 c
all with fibromyalgia, 35–56 years of a
X  SD; 46:6 5:2ð Þ
Notes: X  SD, mean ± standard deviation; HRR, heart rate reserve; RM, repetition m
those related to depressive symptoms as the outcome; Data presented limited to thDiscussion
Findings
The purpose of the current study was to conduct a sys-
tematic review of previous meta-analyses addressing the
effects of exercise (aerobic, strength training or both) in
the treatment of depressive symptoms in adults with
osteoarthritis, rheumatoid arthritis, fibromyalgia or sys-
temic lupus erythematous. While no meta-analyses were
included for participants with osteoarthritis, rheumatoid
arthritis or systemic lupus erythematous, two meta-
analyses in fibromyalgia participants met the eligibility cri-
teria [30,37]. Generally speaking, it appears that exerciseInterventions
ontrol),
ge
Supervised/unsupervised aerobic and strength training
interventions lasting 6 to 23 weeks X  SD; 14 7 weeksð Þ,
frequency (2-5x week), duration (18–90 minutes per session),
intensity (aerobic, 40% -75% HRR; strength, 40%-80% 1RM)
ontrol),
ge
Supervised/unsupervised aerobic exercise lasting 6–26 weeks
X  SD; 13 6ð Þ, frequency 1−7x week; X  SD; 3 1ð Þ, duration
15−45 minutes per session; X  SD; 31 10ð Þ, intensity
(40%-85% MHR), compliance 38%−92%; X  SD; 62 19ð Þ
aximum, MHR, maximum heart rate; Description of meta-analyses limited to
at which was reported or could be calculated from reported data.
Table 2 Overall post-treatment standardized mean difference (SMD) effect sizes for depressive symptoms from
included meta-analyses
Reference ES/Participants (No.) SMD (95% CI) Z(p) Q (p) I2 (%) τ2 PI (95%)
Busch et al. (2006) [30]a 6/294 −0.61 (−0.99 to −0.23) −3.12(0.002)* 12.0 (0.04)** 58.4 0.13 −1.74, 0.53
Hauser et al. (2010) [37] 19/870 −0.32 (−0.53 to −0.12) −3.13(0.002)* 37.0 (0.005)** 51.4 0.22 −1.32, 0.68
Notes: No, Number; ES, effect size; SMD, standardized mean difference; 95% CI, 95% confidence intervals; Z(p), Z-value and probability value for Z; Q(p), Cochran’s
Q statistic and associated alpha (p) value for Q; I2, I-squared statistic for heterogeneity; τ2, tau-squared; PI, prediction intervals, based on a random-effects model;
SMD (95% CI) based on random-effects model; Boldfaced values indicate continuous data with non-overlapping confidence intervals; *, statistically significant,
p ≤ 0.05; **, statistically significant, p ≤ 0.10; a , original meta-analysis did not pool results as done here, but rather, reported separate subgroup results for aerobic
exercise studies meeting the American College of Sports Medicine recommendations [31,32] (4 studies), those not meeting the recommendations (1 study) and
those limited to strength training exercise (1 study).
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gia. This interpretation is supported by (1) the non-
overlapping confidence intervals for SMDs, (2) statistical
significance of the SMDs, (3) sensitivity of results with each
study deleted from the model once, (4) cumulative meta-
analysis, (5) low NNT, (6) absolute number of people in
the US who might benefit by starting and maintaining an
exercise program, (7) percentile improvements as a result
of exercise and (8) good overall methodological quality of
each meta-analysis as assessed by the AMSTAR instru-
ment. However, for both [30,37], a statistically significant
and relatively large amount of heterogeneity was observed
as well as overlapping prediction intervals. In addition,
small-study effects were found for the Hauser et al. [37]
meta-analysis and based on the work of others [44], may
have been underpowered for the Busch et al. [30] study.
Consequently, the strength of the overall findings may be
weakened by these results.
The overall findings of the included meta-analyses
compare quite favorably to the effects of pharmaco-
logic interventions on depressive symptoms in adults
with fibromyalgia. For example, Hauser et al. [45] con-
ducted a meta-analysis of randomized controlled trials
on the effects of antidepressants (tricyclic and tetra-
cyclic antidepressants, selective serotonin reuptake inhib-
itors, serotonin and noradrenaline reuptake inhibitors,
monoamine oxidase inhibitors) on depressed mood in
adults with fibromyalgia. Across 10 SMDs that in-
cluded 887 participants (451 treatment, 436 control) a
small SMD improvement of −0.26 (95% CI, −0.39, −0.12,
p < 0.001) was reported. However, in contrast to the exer-
cise meta-analyses included in the current study [30,37],
no statistically significant heterogeneity was observedTable 3 NNT, number whose depressive symptoms could ben
Reference NNT (95% CI) Number Benefitting (95
Busch et al. (2006) [30] 6 (4, 13) 0.83 (1.25, 0
Hauser et al. (2010) [37] 9 (6, 23) 0.56 (0.83, 0
Notes: NNT, number needed to-treat; 95% CI, 95% confidence intervals; a, gross esti
depressive symptoms if they started and maintained a regular exercise program. Ba
that none exercise regularly; b, Cohen’s U3 Index [38].(Q = 6.39, p = 0.70, I2 = 0%). Thus, while the effects of an-
tidepressants were generally smaller [45], the results were
more consistent than the two exercise meta-analyses
included in the current study [30,37]. The former not-
withstanding, one should also consider the potential
side-effects and costs of any type of pharmacotherapy, in-
cluding antidepressants.
Implications for research
The results of the current systematic review of previous
meta-analyses have at least eight implications for future
research. First, while the overall quality of both meta-
analyses was considered to be good, there are several
areas that might be improved upon in future meta-
analytic work. These include avoiding the use of publica-
tion status as an inclusion criterion as well as documenting
and providing a list of not only included studies but also
excluded studies, including the reasons for exclusion.
While there is little doubt in the investigators’ minds re-
garding the latter recommendation, avoiding the use of
publication status as an inclusion criterion could be ques-
tioned. For example, van Driel et al. suggested that (1) the
difficulty in retrieving unpublished work could lead to se-
lection bias, (2) many unpublished trials are eventually
published, (3) the methodological quality of such studies
are poorer than those that are published, and (4) the effort
and resources required to obtain unpublished work may
not be warranted [46].
Second, both included studies were aggregate data
meta-analyses [30,37]. While still the most common type
of meta-analysis, individual-participant data meta-analyses
(IPD) have been suggested to be the gold standard when
attempting to quantitatively combine data from differentefit from exercise, and percentile improvement
% CI) (millions)a U3 Index (95% CI)
b (Percentile Improvement)
.38) 22.9 (9.1, 33.9)
.22) 12.6 (4.8, 20.2)
mate of the number of US people with fibromyalgia who could improve their
sed on an estimated 5 million US people with fibromyalgia [4] and assuming
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may want to consider using the IPD approach when ad-
dressing the effects of exercise in the treatment of depres-
sive symptoms in adults with arthritis and other rheumatic
diseases. However, the use of the IPD approach needs to
be considered with respect to the ability to retrieve IPD
from investigators as well as the increased costs and time
associated with the conduct of such [48].
Third, given the apparent paucity of data available on
adverse events and cost-effectiveness in the original
studies included in both meta-analyses [30,37], there is a
need for future randomized controlled trials to collect
and report this information. The inclusion of such infor-
mation is critical when making decisions regarding which
interventions to recommend over others.
Fourth, the dose–response effects of exercise on de-
pressive symptoms in adults with fibromyalgia are still
unknown. While the meta-analysis by Hauser et al.
found no statistically significant differences between
either low or moderate intensity aerobic exercise and
land versus water-based exercise [37], future research in
this area appears warranted. Greater knowledge of the
dose–response effects of exercise on depressive symp-
toms in adults with fibromyalgia should lead to better
treatment in this population.
Fifth, no meta-analysis that was limited to the effects
of exercise on depressive symptoms in adults with osteo-
arthritis, rheumatoid arthritis or systemic lupus ery-
thematous met the eligibility criteria for the current
study. Since the effects of exercise on depressive symp-
toms may vary across different populations, it appears
plausible to suggest that future meta-analytic work be
limited and focused on these groups. This is of course
assuming that previous randomized controlled trials have
assessed depressive symptoms in these populations.
Sixth, because neither meta-analysis reported NNT
with respect to depressive symptoms [30,37], it is suggested
that future meta-analytic work include such. From the in-
vestigators’ perspective, the inclusion of such information
is important because it provides practically relevant infor-
mation to decision-makers (practitioners, policy-makers,
etc.) regarding the effects of exercise on depressive symp-
toms in adults with fibromyalgia.
Seventh, given the significant heterogeneity in the in-
cluded meta-analyses, future meta-analytic research on
depressive symptoms in adults with fibromyalgia should
try and identify the sources of this heterogeneity. Broadly,
this may include such things as participant characteristics
(for example, age, gender), intervention characteristics (for
example, length, frequency, intensity, duration, mode) and
outcome assessment methods (for example, type of instru-
ment used to assess depression). Again, this is of course as-
suming that sufficient data are available to examine these
potential predictors.Eighth, the majority of the participants that comprised
both meta-analyses were women [30,37]. The inclusion
of primarily women for the studies nested within each
meta-analysis appears plausible given that the prevalence
of fibromyalgia is greater in women than men [4]. How-
ever, it would appear appropriate to suggest that future
research examine the effects of exercise on depressive
symptoms in men to ensure that no differences in re-
sponse exist.
Implications for practice
The results of the current systematic review of previous
meta-analyses have important implications for practice.
First, while there was a lack of adverse event and cost-
effectiveness data as well as substantial between-study
heterogeneity in both meta-analyses [30,37], exercise ap-
pears to improve depressive symptoms in adults with
fibromyalgia and could be recommended as part of an
overall treatment plan that may also include education
and/or pharmacotherapy. This exercise recommendation
is consistent with previous recommendations on aerobic
and strength training for a variety of outcomes in adults
with fibromyalgia [49,50]. Second, while the dose–response
effects of exercise in the treatment of depressive symp-
toms in adults with fibromyalgia have not been firmly
established [51], it would appear prudent to recommend
that practitioners follow the general recommendations
described by Skinner [51]. These include exercise pro-
grams that (1) minimize any increase in pain, fatigue or
other symptoms, (2) begin at a low level and progress
gradually, (3) allow for day to day variations based on
how the participant feels, (4) improve the physiological
and psychological functioning of the participant and
(5) promote long-term adherence [51]. More specifically,
a combined program of low to moderate intensity aerobic
exercise (walking and swimming for example) combined
with low to moderate intensity strength training may be
better tolerated than high intensity activity [51]. Given
the day to day variation in how fibromyalgia partici-
pants may feel, intensity may be better monitored using
something like rating of perceived exertion scales [52-55]
versus a percentage of 1-repetition maximum (strength
training) and maximum heart rate, heart rate reserve or
percentage of maximum oxygen consumption (aerobic
training) [51].
Strengths and potential limitations of current study
There are at least five strengths of the current study.
First, to the best of the authors’ knowledge, this is the
first systematic review of previous meta-analyses that
has examined the effects of exercise on depressive symp-
toms in adults with arthritis and other rheumatic dis-
ease, an increasingly important approach for addressing
the effects of various healthcare interventions and making
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additional analyses conducted based on the available
data (small-study effects, influence analysis, NNT, etc.),
helped strengthen the information from which conclu-
sions could be drawn from both included meta-analyses
[30,37]. Third, the calculation and inclusion of PIs for
the overall results from each included meta-analysis pro-
vides investigators with information that can aid them in
planning future randomized controlled trials examining
the effects of exercise on depressive symptoms in adults
with fibromyalgia. Fourth, the investigative team believes
that the calculation of percentile improvements, NNT
and gross estimates of the absolute number of adults
with fibromyalgia who could improve their depressive
symptoms by initiating and maintaining a program of
regular exercise enhances the practical applicability and
importance of findings. Fifth, while the inclusion of only
two meta-analyses may initially appear to be a limitation
of the current study, the investigators view this as a
strength given that as many as 32 SMDs on depressive
symptoms in as many as 870 participants across multiple
studies were included. To put this in perspective, the
Cochrane Collaboration suggests that the minimum num-
ber of studies needed to conduct a meta-analysis is two
[8]. Given this line of thinking, it would appear plausible
to suggest that the minimum number of meta-analyses
that need to be included in a study of systematic reviews
with meta-analyses is one.
While there are several strengths of the current study,
there are also at least four potential limitations. First,
the investigative team focused on depressive symptoms
[30,37]. While more focused and applicable, other rele-
vant outcomes (anxiety, quality of life, quality of sleep,
pain, fatigue, stiffness, physical function) were not cap-
tured. Second, the gross population estimates for the
number of people in the US with fibromyalgia who
could improve their depressive symptoms by beginning
and maintaining a regular exercise program assumed
that none of those with fibromyalgia in the US exercise
on a regular basis. Unfortunately, the investigative team
is not aware of any current research on the prevalence
of physical activity in US adults with fibromyalgia, and
thus, was unable to adjust for such. In addition, it was
not possible to adjust for any other potentially con-
founding factors (for example, age). Therefore, the re-
ported estimates might be inflated. Third, as with any
systematic review, many of the biases inherent in both
the included meta-analyses as well as the randomized
controlled trials that comprised each meta-analysis may
have also been present in the current study. Fourth,
while results were generalized to both men and women,
the majority of participants included in both meta-
analyses were women [30,37]. Thus, such a generalization
may have been inappropriate.Conclusions
The results of the current systematic review of previous
meta-analyses suggest that exercise improves depressive
symptoms in adults with fibromyalgia. However, a need
exists for additional meta-analytic work in this area, in-
cluding, but not limited to, the inclusion of adults with
osteoarthritis, rheumatoid arthritis and systemic lupus
erythematous.
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